Japan Tobacco (2914) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Revenue and profit grew in the first half of 2024, led by strong tobacco pricing and RRP growth, with processed food also supporting profit.
Operating profit rose 4.6% and net profit increased 6.3% year-on-year, supported by lower financial costs and improved working capital.
Comprehensive income surged 48% year-on-year to ¥791.9 billion, driven by strong foreign currency translation gains.
Upward revision of full-year forecasts for revenue, AOP, and profit, reflecting strong first-half results and favorable FX.
Free cash flow grew by ¥24.9 billion to ¥179.8 billion.
Financial highlights
Consolidated revenue for Jan–Jun 2024: ¥1,569.9B, up 12.7% year-over-year; core revenue up 6.2% at constant FX.
Adjusted operating profit (AOP): ¥454.8B, up 2.7% at constant FX; reported AOP: ¥453.1B, up 2.3%.
Operating profit: ¥432.7B, up 4.6%; net profit: ¥305.2B, up 6.3% year-over-year.
Free cash flow: ¥179.8B, an increase of ¥24.9B year-over-year.
RRP (Reduced-Risk Products) volume up 25.5% year-on-year; RRP revenue up 29%.
Outlook and guidance
Full-year 2024 revenue forecast revised up to ¥3,109.0B (+9.4% vs. 2023); core revenue at ¥2,856.0B (+4.7%).
AOP forecast raised to ¥745.0B at constant FX (+2.3%); reported AOP to ¥710.0B.
Operating profit forecast at ¥660.0B; net profit at ¥475.0B.
Annual dividend forecast maintained at ¥194 per share; payout ratio projected at 73%.
Total tobacco volume expected to decline 0.5–1% year-on-year, with RRP growth offset by combustibles decline.
Latest events from Japan Tobacco
- Record profit and revenue growth in 2025, with strong outlook and RRP investment focus for 2026.2914
Q4 202512 Feb 2026 - Q1 2025 delivered strong profit growth, pharma divestment, and new Ploom launch ahead.2914
Q1 20253 Feb 2026 - Revenue up 11% and US market share expanded via Vector, but profit faces cost and litigation risks.2914
Q3 202417 Jan 2026 - Record revenue and AOP in 2024, with high single-digit growth and RRP expansion targeted.2914
Q4 20248 Jan 2026 - Strong revenue and profit growth led to higher forecasts and dividend guidance for 2025.2914
Q2 20255 Nov 2025 - Record-high profit and revenue, higher guidance, and increased dividend after business divestiture.2914
Q3 202530 Oct 2025